Press release
Seven Major Markets Slated to See a Rise in 23.5% Diagnosed Cases of Bladder Cancer by 2025
EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025
Summary
Bladder cancer is a commonly diagnosed cancer and causes significant numbers of cancer deaths worldwide. The major risk factors for bladder cancer are exposure to smoking and occupational risk factors such as exposure to aromatic amines. These risk factors are more prevalent among men, which makes the disease significantly more common in men than women. The majority of bladder cancer cases are among older individuals, with the median age at diagnosis being 73 years; because of this, the comorbidities associated with bladder cancer are similar to conditions typically occurring in older age, and therefore are not specific to bladder cancer.
GlobalData epidemiologists forecast that by 2025, the 7MM are expected to have 289,623 diagnosed incident cases of bladder cancer, representing a 23.5% increase from the number of incident cases in 2015 (234,581 incident cases).
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=915866
In 2015, the 7MM had 873,493 five-year diagnosed prevalent cases of bladder cancer and GlobalData epidemiologists forecast that by 2025, this number will grow to 1,094,707 five-year diagnosed prevalent cases at an Annual Growth Rate (AGR) of 2.53%.
This forecast is supported by at least 10 years of historical data obtained from country-specific studies published by the World Health Organizations (WHO) International Agency for Research on Cancer (IARC), the National Cancer Institutes (NCI) Surveillance, Epidemiology, and End Results (SEER) program, the European Cancer Registrys fifth database registry (EUROCARE-5), the Center for Cancer Control and Information Services, National Cancer Center (CCCIS, NCC) in Japan, as well as country-specific cancer registries. Another major strength of this analysis is that GlobalData epidemiologists were able to forecast incident cases of bladder cancer in the 7MM by age, sex, and stage at diagnosis. Furthermore, the forecast methodology was consistent across all markets, thereby allowing for a meaningful global comparison.
Browse more details @ http://www.researchmoz.us/epicast-report-bladder-cancer-epidemiology-forecast-to-2025-report.html
Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Epidemiology 7
2.1 Disease Background 7
2.2 Risk Factors and Comorbidities 7
2.3 Global Trends 8
2.3.1 Incidence 9
2.3.2 Relative Survival 11
2.4 Forecast Methodology 12
2.4.1 Sources Used Tables 12
2.4.2 Forecast Assumptions and Methods 16
2.4.3 Sources Not Used 20
2.5 Epidemiological Forecast for Bladder Cancer (2015-2025) 21
2.5.1 Diagnosed Incident Cases of Bladder Cancer 21
2.5.2 Age-Specific Diagnosed Incident Cases of Bladder Cancer 22
2.5.3 Sex-Specific Diagnosed Incident Cases of Bladder Cancer 24
2.5.4 Age-Standardized Diagnosed Incidence Rates of Bladder Cancer 26
2.5.5 Diagnosed Incident Cases of Bladder Cancer by Stage at Diagnosis 27
2.5.6 Five-Year Diagnosed Prevalent Cases of Bladder Cancer 27
2.6 Discussion 29
2.6.1 Epidemiological Forecast Insight 29
2.6.2 Limitations of the Analysis 30
2.6.3 Strengths of the Analysis 31
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Seven Major Markets Slated to See a Rise in 23.5% Diagnosed Cases of Bladder Cancer by 2025 here
News-ID: 632314 • Views: …
More Releases from Bladder Cancer
Growth of Bladder cancer Industry : Trends and Application 2017
ALBANY, NY, April 5, 2017 : DelveInsights Bladder cancer - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Bladder cancer forecasted market share for ten years to 2023…
Detailed Analysis Of Bladder Cancer Partnering Deals For The Period 2017 - 2021
Researchmoz added Most up-to-date research on "Detailed Analysis Of Bladder Cancer Partnering Deals For The Period 2017 - 2021" to its huge collection of research reports.
The Bladder Cancer Partnering 2010-2015 report provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in bladder cancer partnering deals
Top bladder cancer deals by value
Deals listed by company A-Z, industry sector, stage of development,…
Detailed Examination Of Bladder Cancer- Market Insights, Epidemiology and Market …
Researchmoz added Most up-to-date research on "Detailed Examination Of Bladder Cancer- Market Insights, Epidemiology and Market Forecast - 2023" to its huge collection of research reports.
DelveInsights Bladder cancer - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics…
New Study Reveals Bladder Cancer - Opportunity Analysis and Forecasts to 2017 | …
Researchmoz added Most up-to-date research on "Bladder Cancer - Opportunity Analysis and Forecasts to 2017" to its huge collection of research reports.
The bladder cancer market has remained largely unchanged in the past 10-20 years. However, significant expansion is expected starting in 2016, with the introduction of several new therapies that are projected to fuel market growth. In addition, bladder cancer has a robust early-stage pipeline that will contribute to market…
More Releases for Diagnosed
Dolutegravir is a first-line treatment for newly diagnosed HIV patients
A new study by UBC researchers is set to change international treatment recommendations for people who are newly diagnosed with HIV--an update that could affect nearly two million people per year worldwide. The study found that dolutegravir is the optimal medication for first-line treatment for people newly diagnosed with HIV, a choice that has not been clear over the past several years.
Dolutegravir (DTG), sold under the brand name Tivicay, is…
ADVOCACY GROUP: Genetic Testing for ALL Newly Diagnosed Pancreatic Cancer
Every newly diagnosed person with pancreatic cancer (ductal adenocarcinoma of the pancreas) should receive genetic screening prior to beginning treatment according to a new recommendation by the nonprofit Cancer Patients Alliance through their Pancreatica.org initiative.
Executive Director, Dale O’Brien, MD, reports, “there appears to be a subtype of pancreatic cancer, about 15%, that can be identified through genetic testing. The important point is that patients in this group often do…
Global Historical And Forecasted Epidemiological Data For Diagnosed Incident Cas …
ResearchMoz presents this most up-to-date research on "Global Historical And Forecasted Epidemiological Data For Diagnosed Incident Cases Of Ovarian Cancer From 2017 - 2020".
DelveInsights Ovarian Cancer - Market Insights, Epidemiology and Market Forecast-2020- US Reports provides an overview of the disease and global market size of the Ovarian Cancer for the United States. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Ovarian Cancer…
Ulcerative Colitis Diagnosed Prevalent Cases Show Prevalence against Diagnosed I …
"The Report EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
The ulcerative colitis (UC) epicast report for the 10-year period 2015–2025 added by MarketResearchReports.biz takes into account seven crucial markets worldwide to shed light on the prevalence of UC. Japan, the U.K., Spain, Italy, Germany, France, and the U.S. are critically studied in…
United States To Have Highest Diagnosed Incident Cases Of Head And Neck Cancers …
Head and neck cancers (HNCs) are on the rise and have led to the development of a massive market offering treatments and therapies for the same. A new report, titled ‘EpiCast Report: Head and Neck Cancers - Epidemiology Forecast To 2024,’ now available on MarketResearchReports.biz studies the state of the market in detail.
The report primarily offers a comprehensive overview of the comorbidities and risk factors associated with head and neck…
Women Diagnosed With Cancer Are Less Likely To Die
Women diagnosed with cancer are less likely to die from the disease than men. Experts acknowledge that the higher rate for men is due to a higher initial risk and later detection.
According to research reported by the National Cancer Institute he highest male-to-female mortality rate ratios for cancers are lip cancer, where 5.5 men died for each woman patient, and esophageal, where 4 men died for each woman patient.
The…
